Panna Sharma, CEO of Lantern Pharma, discusses how his company is bringing cancer therapies to the market faster, cheaper and at a lower cost than other biotechs through artificial intelligence, machine learning and genomic data. He emphasizes that it shouldn’t cost $2 billion to make medicine. He shares it costs this much because Big Pharma is artificially inflating pricing. 

Lantern Pharma is changing healthcare because it is developing new medicines significantly cheaper than big pharma, in a time frame that is unheard of, with only a dozen people.